• ESMIRTAZAPINE CHEMBL1366933

    Alternate Names:

    Esmirtazapine
    (7S)-5-METHYL-2,5,19-TRIAZATETRACYCLO[13.4.0.0(2),?.0?,(1)(3)]NONADECA-1(19),8,10,12,15,17-HEXAENE
    (S)-1,2,3,4,10,14B-HEXAHYDRO-2-METHYLPYRAZINO(2,1-A)PYRIDO(2,3-C)(2)BENZAZEPINE
    UNII-A051Q2099Q COMPONENT RONZAEMNMFQXRA-MRXNPFEDSA-N
    PL004627
    4685R51V7M
    PDSP2_001514
    PDSP1_001530
    EINECS 262-714-0
    ZINC968310
    ORG-44-20
    ORG 44-20
    SCHEMBL49330
    BIDD:PXR0200
    AC1MJ43F
    ESMIRTAZAPINE [INN]
    (+)-MIRTAZAPINE
    61337-87-9
    UNII-4685R51V7M
    3085218
    DB06678

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications for treatment of insomnia,for treatment of menopausal symptoms
    Drug Categories therapeutic uses
    Drug Categories psychotropic drugs
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories neurotransmitter agents
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories histamine h1 antagonists
    Drug Categories histamine antagonists
    Drug Categories histamine agents
    Drug Categories heterocyclic compounds, 3-ring
    Drug Categories heterocyclic compounds
    Drug Categories dibenzazepines
    Drug Categories cytochrome p-450 cyp2d6 substrates
    Drug Categories chemical actions and uses
    Drug Categories central nervous system agents
    Drug Categories carbon radioisotopes
    Drug Categories antidepressive agents, tricyclic
    Drug Categories antidepressive agents
    Drug Categories adrenergic antagonists
    Drug Categories adrenergic alpha-antagonists
    Drug Categories adrenergic agents
    Drug Groups investigational
    Drug Type small molecule
    (0 More Sources)